Analysis of solvent-exposed and buried co-crystallized ligands: a case study to support the design of novel protein–protein interaction inhibitors
- 1 February 2019
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 24 (2) , 551-559
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- BDDCS, the Rule of 5 and drugabilityAdvanced Drug Delivery Reviews, 2016
- An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposesALTEX, 2014
- Going further than Lipinski's rule in drug designExpert Opinion on Drug Discovery, 2012
- Physicochemical drug properties associated within vivotoxicological outcomes: a reviewExpert Opinion on Drug Metabolism & Toxicology, 2009
- Generation of a Set of Simple, Interpretable ADMET Rules of ThumbJournal of Medicinal Chemistry, 2008
- Pursuing the leadlikeness concept in pharmaceutical researchCurrent Opinion in Chemical Biology, 2004
- Multiobjective Optimization in Quantitative Structure−Activity Relationships: Deriving Accurate and Interpretable QSARsJournal of Medicinal Chemistry, 2002
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- Molecular Descriptors in Chemoinformatics, Computational Combinatorial Chemistry, and Virtual ScreeningCombinatorial Chemistry & High Throughput Screening, 2000